|
Immunogenicity and safety study of two formulations of GlaxoSmithKline (GSK) Biologicals’ pneumococcal vaccine (2830929A and 2830930A) when administered in healthy infants |
GSK2830929A; GSK2830930A |
116485 |
NCT01616459 2011-005743-27 |
Streptococcus pneumoniae |
Phase 2 |
|
|
|
|
|
June 2019 |